BackgroundAcute kidney injury (AKI) is caused by a loss of kidney function. This leaves the body unable to remove waste products, and balance water and electrolyte levels effectively. Some people with AKI may experience it short-term and recover their kidney function. For others, AKI may progress further and develop into chronic kidney disease (CKD), especially for those who have other co-existing conditions that require treatment. People who have recovered from AKI, however, have an increased risk of other health problems or even having AKI again in the future.A new class of oral anti-hyperglycaemic drugs, called sodium glucose co-transporter 2 (SGLT2) inhibitors, were initially used in the treatment of T2DM. They work by increasing the removal of glucose, and in turn lowering blood glucose levels. There is now a growing amount of research evidence to show SGLT2 inhibitors have additional benefits in people who are at risk of cardiovascular and kidney disease. SGLT2 inhibitors have been shown to reduce the p

Background Acute kidney injury (AKI) is a condition where the kidneys are damaged, and their function reduced. This can lead to a build-up of fluid in the body, decreased urine output and an increase in toxins in the blood. AKI may be short-term, with people recovering the function of their kidneys. In other people, the disease progresses, and mortality rates can be as high as 45%. In adults who are admitted to hospital, up to 20% will be diagnosed with AKI as the primary reason for being admitted. Research from both Australia and the US have shown the rate of AKI to have increased greatly over the past 10 years, and that this trend will continue to rise. With significant impacts on people’s quality of life, AKI is an increasing global healthcare issue. Most research into the incidence of AKI is from within the intensive care unit (ICU). However, the rate of AKI diagnosed outside the ICU is much larger. This can be due to physical injury to the kidneys, kidney stones, infection of the kidneys, damage c

BackgroundIn India, transgender individuals face a disproportionate burden of mental illness, yet their mental health remains largely under-researched. Studies have revealed alarming statistics, such as 42.7% of transwomen experiencing moderate to severe depression and 48% suffering from psychiatric disorders. This is in stark contrast to the approximate 14% prevalence among gender conforming individuals. Recognizing mental health as a global priority, the United Nations has emphasized addressing mental illness as crucial for sustainable development.AimsOur project aims to address this pressing issue by conducting a preliminary evaluation of a peer support model tailored to the needs of transgender individuals in the National Capital Region (NCR) of Delhi. We seek to explore the effects of this model on anxiety, depression, suicide/self-harm rates, and overall psychological wellbeing. Additionally, we aim to assess the acceptability of the peer support approach and identify factors that facilitate or impede i